Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
ABSTRACT Background Cytokine‐induced killer (CIK) cell therapy has proven successful in clinical trials regarding glioblastoma. Equally important are the hints suggesting peroxisome proliferator‐activated receptors (PPARs) ligands being co‐expressed in the central nervous system (CNS). This provides...
Saved in:
Main Authors: | Kira Vordermark, JingJing Pu, Amit Sharma, Jarek Maciacyzk, Ingo G. H. Schmidt‐Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70497 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
by: Annika Simone Lück, et al.
Published: (2025-01-01) -
RETRACTED ARTICLE: NR3C2 affects the proliferation and invasiveness of colon cancer cells through the Wnt/β-Catenin signaling pathway
by: Ke Nie, et al.
Published: (2024-09-01) -
Early embryonic developmental toxicity of TPhP and CDP: Roles of PPARγ
by: Jing HUANG, et al.
Published: (2024-12-01) -
Molecular docking of ferulic acid, bakuchiol and niazirin on peroxisome proliferator-activated receptor gamma (PPAR-γ) as anti-diabetic agents
by: Anjar Hermadi Saputro, et al.
Published: (2024-08-01) -
Expression study of Wnt/β-catenin signaling pathway associated lncRNAs in schizophrenia
by: Fatemeh Manafzadeh, et al.
Published: (2025-01-01)